Advanced Filter

Filter by Group

Filter by Market Availability

Displaying 1 drug
Olmesartan is a nonpeptide antihypertensive with no chiral centers.Orally available olmesartan is usually presented in the form of olmesartan medoxomil which is a prodrug rapidly converted in vivo to the pharmacologically active olmesartan.It was developed by Daiichi Sankyo Pharmaceuticals and approved in 2002.[A175345, L5560]
Approved
Investigational
Displaying 1 drug